Detroit Office of the Food and Drug Administration (FDA) has concluded the re-inspection of Perrigo's Allegan facility.
Subscribe to our email newsletter
The FDA has informed Perrigo that, effective immediately, the company has an acceptable regulatory status, such that any pending export license and ANDA applications from this facility will once again be eligible for review and approval.
Perrigo is a healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.